Results 231 to 240 of about 549,247 (252)

Binding of LAG-3 to stable peptide-MHC class II limits T cell function and suppresses autoimmunity and anti-cancer immunity

Immunity, 2022
Il-Mi Okazaki, Daisuke Sugiura, Takeo Meda   +2 more
exaly  

LAG-3 as a Potent Target for Novel Anticancer Therapies of a Wide Range of Tumors

International Journal of Molecular Sciences, 2022
Julita Kulbacka, Katarzyna Karłowicz-Bodalska, Wojciech Szlasa   +2 more
exaly  

The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application

Frontiers in Immunology, 2022
Zhang-Suo Liu
exaly  

Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity.

Immunotherapy Advances, 2022
Awen Gallimore, Andrew Godkin, Bruce J MacLachlan   +2 more
exaly  

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

Cell, 2019
Kurt A Schalper, Linghua Zheng, Ting Zhou   +2 more
exaly  

LAG-3+ tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+ tumors

Annals of Oncology, 2017
S K Chia
exaly  

Predictive modelling of the microbial lag phase: a review

International Journal of Food Microbiology, 2004
Kristel Bernaerts, J F van Impe, A H Geeraerd   +2 more
exaly